Digital health · DeepTech
How Katana Labs turned contacts into real conversations.
Groundbreaking technology, clear impact, but reaching the right decision-makers in clinics and biopharma companies was complex. DealEngine structured the reach into the target group.
4,8×
higher conversion rate
38 %
response rate
5,3×
more qualified pilot talks
The starting point
With its AI platform Katana Edge, Katana Labs has developed a technology that fundamentally changes tumour analysis. The Dresden-based startup works with leading research institutions and is on an international growth path in life sciences and biopharma.
Our approach
- 1 Decision-maker mapping across biopharma companies, university hospitals and research institutes by role, research focus and innovation affinity.
- 2 Scientifically grounded messaging that centres on clinical benefit and time savings.
- 3 Structured conversation preparation with a technical briefing for a direct entry at pilot level.
„Access to the right decision-makers was our biggest challenge. DealEngine solved it."
Ready for full calendars?
A 10-minute intro call. We look together at whether it fits. If it does, we start next week.
- No sales pitch
- No commitment
- 10 minutes